ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

CTRF Seeks Applications In Clinical Cancer Research.

January 28, 2000

RFA For Patient Compliance Study

September 26, 1980

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

Calif., Illinois Enact ACCC Model Law On Reimbursement

October 23, 1992

Letter Protests Closed Meeting; NIH Calls Action Appropriate

August 12, 1994